Log In
Print
BCIQ
Print
Print this Print this
 

EV-035

  Manage Alerts
Collapse Summary General Information
Company Evolva Holding S.A.
DescriptionPyridone-based topoisomerase inhibitors
Molecular Target Topoisomerase II (TOP2)
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat bacterial infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today